BSE Live
Dec 29, 16:01Prev. Close
1440.30
Open Price
1425.60
Bid Price (Qty.)
1408.00 (1)
Offer Price (Qty.)
1433.75 (5)
NSE Live
Dec 29, 15:59Prev. Close
1439.80
Open Price
1432.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Ipca Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 51.64 | 36.01 | 18.47 | 14.92 | 7.33 | |
| Diluted EPS (Rs.) | 51.60 | 36.01 | 18.47 | 14.92 | 7.33 | |
| Cash EPS (Rs.) | 65.78 | 49.61 | 32.29 | 28.47 | 20.11 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 291.06 | 248.25 | 213.55 | 196.13 | 180.91 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 291.06 | 248.25 | 213.55 | 196.13 | 180.91 | |
| Dividend / Share(Rs.) | 5.00 | 3.00 | 1.00 | 1.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 345.66 | 287.55 | 253.04 | 245.82 | 222.16 | |
| PBDIT/Share (Rs.) | 77.52 | 59.18 | 38.13 | 35.86 | 23.87 | |
| PBIT/Share (Rs.) | 63.38 | 45.58 | 24.31 | 22.31 | 11.10 | |
| PBT/Share (Rs.) | 62.13 | 44.11 | 22.41 | 20.46 | 8.83 | |
| Net Profit/Share (Rs.) | 51.64 | 36.00 | 18.47 | 14.92 | 7.33 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 22.42 | 20.58 | 15.06 | 14.58 | 10.74 | |
| PBIT Margin (%) | 18.33 | 15.85 | 9.60 | 9.07 | 4.99 | |
| PBT Margin (%) | 17.97 | 15.34 | 8.85 | 8.32 | 3.97 | |
| Net Profit Margin (%) | 14.93 | 12.52 | 7.29 | 6.06 | 3.29 | |
| Return on Networth / Equity (%) | 17.74 | 14.50 | 8.64 | 7.60 | 4.05 | |
| Return on Capital Employed (%) | 20.30 | 16.72 | 7.48 | 6.23 | 3.14 | |
| Return on Assets (%) | 12.58 | 10.20 | 5.67 | 4.74 | 2.36 | |
| Total Debt/Equity (X) | 0.11 | 0.11 | 0.18 | 0.21 | 0.29 | |
| Asset Turnover Ratio (%) | 84.23 | 81.50 | 77.74 | 78.18 | 71.80 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.18 | 2.25 | 1.92 | 1.81 | 1.67 | |
| Quick Ratio (X) | 1.16 | 1.21 | 1.04 | 0.89 | 0.80 | |
| Inventory Turnover Ratio (X) | 3.45 | 3.44 | 3.66 | 3.55 | 3.37 | |
| Dividend Payout Ratio (NP) (%) | 15.49 | 2.77 | 5.41 | 0.00 | 13.64 | |
| Dividend Payout Ratio (CP) (%) | 12.16 | 2.01 | 3.09 | 0.00 | 4.97 | |
| Earnings Retention Ratio (%) | 84.51 | 97.23 | 94.59 | 0.00 | 86.36 | |
| Cash Earnings Retention Ratio (%) | 87.84 | 97.99 | 96.91 | 0.00 | 95.03 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 17,773.89 | 12,485.14 | 8,606.86 | 8,378.19 | 7,821.61 | |
| EV/Net Operating Revenue (X) | 4.07 | 3.44 | 2.70 | 2.70 | 2.79 | |
| EV/EBITDA (X) | 18.15 | 16.70 | 17.89 | 18.51 | 25.96 | |
| MarketCap/Net Operating Revenue (X) | 4.02 | 3.42 | 2.59 | 2.54 | 2.61 | |
| Retention Ratios (%) | 84.50 | 97.22 | 94.58 | 0.00 | 86.35 | |
| Price/BV (X) | 4.77 | 3.96 | 3.07 | 3.18 | 3.20 | |
| Price/Net Operating Revenue | 4.02 | 3.42 | 2.59 | 2.54 | 2.61 | |
| Earnings Yield | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 |
05.12.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
17.11.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher